Circ_0008717 promotes renal cell carcinoma progression by upregulating FBXO17 via targeting miR-217
- PMID: 35357059
- DOI: 10.1002/jgm.3418
Circ_0008717 promotes renal cell carcinoma progression by upregulating FBXO17 via targeting miR-217
Abstract
Background: Renal cell carcinoma (RCC) is a common lethal urological malignancy. Circular RNAs are assumed to play important roles in cancer development. The objective of the present study was to investigate the role and action mechanism of circ_0008717 in RCC.
Methods: The expression of circ_0008717, miR-217 and F-box protein 17 (FBXO17) mRNA was detected by a real-time quantitative polymerase chain reaction. Cell proliferation was examined using a cell counting kit-8 assay and an 5-ethynyl-2'-deoxyuridine assay. Cell apoptosis was assessed by a flow cytometry assay. Cell migration and cell invasion were investigated using a transwell assay. Glycolysis progression was assessed according to the levels of glucose uptake and lactate production. The expression of glycolysis-related proteins and FBXO17 protein was quantified by western blotting. The targets were analyzed by the bioinformatics tools (starBase and circinteractome) and validated by a dual-luciferase reporter assay, RNA pull-down assay and RNA immunoprecipitation assay. A xenograft model was established to monitor the role of circ_0008717 in vivo.
Results: Circ_0008717 was upregulated in RCC tissues and cells. Silencing circ_0008717 suppressed RCC cell proliferation, migration, invasion and glycolysis but promoted cell apoptosis. MiR-217 was a target of circ_0008717 and bound to the FBXO17 3' untranslated region. The expression of FBXO17 was positively regulated by circ_0008717 but impaired by miR-217 reintroduction. The inhibitory effects of circ_0008717 knockdown on RCC cell malignant behaviors were reversed by miR-217 inhibition or FBXO17 overexpression. Circ_0008717 knockdown inhibited tumor growth in vivo by regulating miR-217 and FBXO17.
Conclusions: Circ_0008717 aggravated the progression of RCC by activating FBXO17 through targeting miR-217, which provided a novel mechanism for circ_0008717 to participate in RCC progression.
Keywords: FBXO17; RCC; circ_0008717; miR-217.
© 2022 John Wiley & Sons, Ltd.
Similar articles
-
Silencing circular RNA circ_0054537 and upregulating microRNA-640 suppress malignant progression of renal cell carcinoma via regulating neuronal pentraxin-2 (NPTX2).Bioengineered. 2021 Dec;12(1):8279-8295. doi: 10.1080/21655979.2021.1984002. Bioengineered. 2021. PMID: 34565284 Free PMC article.
-
Circ_0005875 sponges miR-502-5p to promote renal cell carcinoma progression through upregulating E26 transformation specific-1.Anticancer Drugs. 2022 Jan 1;33(1):e286-e298. doi: 10.1097/CAD.0000000000001205. Anticancer Drugs. 2022. PMID: 34407050
-
Circ_0000274 contributes to renal cell carcinoma progression by regulating miR-338-3p/NUCB2 axis and JAK1/STAT3 pathway.Transpl Immunol. 2022 Oct;74:101626. doi: 10.1016/j.trim.2022.101626. Epub 2022 May 13. Transpl Immunol. 2022. PMID: 35569717
-
Circ_0037866 Contributes to the Tumorigenesis of Renal Cell Carcinoma by Sequestering miR-384 to Elevate Chromobox 5 Expression.Kidney Blood Press Res. 2022;47(5):329-340. doi: 10.1159/000522190. Epub 2022 Mar 4. Kidney Blood Press Res. 2022. PMID: 35249038
-
The emerging role of long non-coding RNAs in renal cell carcinoma progression and clinical therapy via targeting metabolic regulation.Front Pharmacol. 2023 Mar 9;14:1122065. doi: 10.3389/fphar.2023.1122065. eCollection 2023. Front Pharmacol. 2023. PMID: 36969848 Free PMC article. Review.
Cited by
-
hsa_circ_0003596, as a novel oncogene, regulates the malignant behavior of renal cell carcinoma by modulating glycolysis.Eur J Med Res. 2023 Sep 2;28(1):315. doi: 10.1186/s40001-023-01288-z. Eur J Med Res. 2023. PMID: 37660068 Free PMC article.
-
Role of the circular RNAs/microRNA/messenger RNA axis in renal cell carcinoma: From gene regulation to metabolism and immunity.iScience. 2025 Mar 11;28(4):112183. doi: 10.1016/j.isci.2025.112183. eCollection 2025 Apr 18. iScience. 2025. PMID: 40212586 Free PMC article. Review.
-
An integrated bioinformatics approach to identify key biomarkers in the tubulointerstitium of patients with focal segmental glomerulosclerosis and construction of mRNA-miRNA-lncRNA/circRNA networks.Ren Fail. 2023;45(2):2284212. doi: 10.1080/0886022X.2023.2284212. Epub 2023 Nov 27. Ren Fail. 2023. PMID: 38013448 Free PMC article.
-
Non-coding RNAs as potential biomarkers in osteosarcoma.Front Genet. 2022 Oct 19;13:1028477. doi: 10.3389/fgene.2022.1028477. eCollection 2022. Front Genet. 2022. PMID: 36338952 Free PMC article. Review.
-
Therapeutic importance and diagnostic function of circRNAs in urological cancers: from metastasis to drug resistance.Cancer Metastasis Rev. 2024 Sep;43(3):867-888. doi: 10.1007/s10555-023-10152-9. Epub 2024 Jan 22. Cancer Metastasis Rev. 2024. PMID: 38252399 Review.
References
REFERENCES
-
- Tsili AC, Argyropoulou MI. Advances of multidetector computed tomography in the characterization and staging of renal cell carcinoma. World J Radiol. 2015;7(6):110-127. doi:10.4329/wjr.v7.i6.110
-
- Motzer RJ, Agarwal N, Beard C, et al. Kidney cancer. J Natl Compr Canc Netw. 2011;9(9):960-977. doi:10.6004/jnccn.2011.0082
-
- Cancer Genome Atlas Research, N. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499(7456):43-49. doi:10.1038/nature12222
-
- Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet. 2009;373(9669):1119-1132. doi:10.1016/S0140-6736(09)60229-4
-
- Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011;59(4):543-552. doi:10.1016/j.eururo.2010.12.013
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases